TIGO
17.11.2021 23:02:08 CET | Business Wire | Press release
Tigo Energy Inc. , the solar industry’s worldwide leader in Flex MLPE (Module Level Power Electronics), announced today that Australia’s SCE Energy Solutions has deployed more than 7MW of monitored solar energy across 800 commercial, residential, and rural solar installations. SCE has leveraged the Tigo Energy Intelligence (EI) software platform to expand its service-oriented approach to maximize the benefits of the Tigo platform for its clients across Australia.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211117006255/en/
SCE Energy Solutions uses the advanced chart pages for fleet management and kiosk view from Tigo Energy to enable two unique services for clients. Using the data provided by the EI software platform, SCE conducts weekly maintenance checks for system owners to ensure their systems are operating at peak performance. The kiosk view of the EI platform enables SCE to set up a screen for residential and commercial system owners through which they can showcase energy production and their commitment to renewable energy customers, colleagues, and friends.
“In the Tigo monitoring system we have the best available technology to improve the ROI for our customers, and it has a tremendously positive impact for the many businesses that previously wastes up to 50 percent of the energy they pay for,” said Jon De Martin, CEO and managing director at SCE Energy Solutions. “The kiosk feature of the Tigo Energy Intelligence system provides a powerful way for us to make solar visible, displaying the live energy statistics of our customers’ systems, which they can proudly showcase in public spaces at their business locations.”
SCE Energy Solutions has used Tigo TS4 Flex MLPE optimizers with remote module level monitoring since 2012. Since that time, SCE has implemented Tigo’s technology to service system owners throughout the Commonwealth of Australia, monitor their fleet remotely, and help customers highlight their investments in solar energy. Additionally, SCE provides critical feedback to Tigo for continuous improvement to the platform.
“We support installers’ revenue and strategic goals through a holistic approach to energy management, and SCE Energy Solutions is the ideal Tigo customer because they push the technological envelope and embrace innovation,” says Archie Roboostoff, software vice-president at Tigo Energy. “The SCE team exercises every aspect of our EI software solution to service their customers, reduce truck rolls, optimize energy generation, and maximize solar ROI for customers across Australia. We greatly appreciate the dedication SCE brings to their system owners.”
With more than 40,000 sites monitored worldwide, Tigo Energy processes 47,000 data points per second, resulting in almost a petabyte of monitoring and efficiency data. The platform is available on the internet and as a mobile application named Tigo EI on the Apple App Store and Google Play . To see the EI in action for SCE Energy Solutions, please see the unique insights SCE offers into a live solar site in Australia, here: https://ei.tigoenergy.com/p/C-O7B12J5FVS .
To learn more about Tigo Energy, visit www.tigoenergy.com .
About Tigo Energy
Tigo Energy is the worldwide leader in Flex MLPE (Module Level Power Electronics) with innovative solutions that increase solar energy production, decrease operating costs, and significantly enhance safety of solar energy systems. The Tigo TS4 platform maximizes the benefit of solar and provides customers with the most scalable, versatile, and reliable MLPE solution available. Tigo was founded in Silicon Valley in 2007 to accelerate the adoption of solar energy worldwide. Tigo systems operate on seven continents and produce gigawatt hours of reliable, clean, affordable, and safe solar energy daily. With a global team, Tigo Energy is dedicated to making the best MLPE on earth so more people can enjoy the benefits of solar. Find us online at www.tigoenergy.com .
About SCE Energy Solutions
SCE Energy Solutions is an award-winning sustainability business that prides itself on providing only the highest quality product and latest technologies available for their commercial, rural and residential customers. They have made it their mission to find technologies where clients can gain control of energy costs. This means developing a renewable energy system that is simple & easy to use with predictable payments and a 25-year warranty. We employ a unique five-step-plan: schedule a call, design the best possible system, install that system, get environmentally certified, and then SCE conducts weekly performance checks. They service all areas of Australia and are located in Concord NSW, Australia. For more information, go to www.sce-energysolutions.com.au .
View source version on businesswire.com: https://www.businesswire.com/news/home/20211117006255/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
First Randomized Controlled Trial Shows Promise of a Ketogenic Diet in Psychotic Disorders8.7.2026 15:00:00 CEST | Press release
Trial reports correlations between ketone levels and cognitive and psychiatric symptoms in individuals with schizophrenia-spectrum and bipolar-1 disorders Published today in Schizophrenia Bulletin, a first-of-its-kind randomized controlled trial (RCT) from researchers at the University of California, San Francisco (UCSF), and funded in part by the National Institute of Mental Health (NIMH), adds to growing literature on the potential benefit of a ketogenic diet for treating psychotic disorders. The study, which enrolled participants with schizophrenia-spectrum or bipolar-1 disorders, demonstrated rapid metabolic improvements with a ketogenic diet compared to diet-as-usual during an initial one-month RCT open-label phase. Furthermore, those who continued with the optional four-month single-arm ketogenic diet extension saw meaningful gains across metabolic, psychiatric, and cognitive measures. This press release features multimedia. View the full release here: https://www.businesswire.co
Teamily AI Publicly Launches Human+AI Social Platform to Make Building and Growing a Company Easy for Every Team8.7.2026 15:00:00 CEST | Press release
Teamily AI (https://Teamily.ai), together with its Agentic AI Infra platform TensorOpera AI (https://TensorOpera.ai), today announced the public launch of its Human+AI social platform, a product stack that has already served more than 5 million users around the world. Starting today in Palo Alto and rolling out simultaneously across dozens of countries, this first public launch opens the full stack to everyone with a single mission: to make building and growing a company easy for every person and every team. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260708584390/en/ "This is the moment we open our doors to the world," said co-founders Dr. Aiden Chaoyang He and Professor Salman Avestimehr. "We want every person and every team to be able to move from idea to product, from product to market, and from market to growth and investment, with an AI-native team by their side." At its core, Teamily AI enables humans and AI agents
Leo Cancer Care Raises $65M Series D to Scale Its Integrated Upright Cancer Care Platform8.7.2026 14:30:00 CEST | Press release
Oversubscribed round follows the world-first compact upright proton treatment at Stanford Medicine — funding a single upright platform that will span imaging and treatment across multiple radiation modalities. Leo Cancer Care, the medical technology company working to reinvent how patients are imaged and treated by designing systems around the body’s natural upright position, today announced the close of an oversubscribed $65 million Series D financing. The round was led by Silicon Valley’s Yu Galaxy and welcomes new investors including Eventide Asset Management, alongside continued support from the company’s existing investors. Leading cancer institutions are already adopting the upright approach. Stanford Medicine delivered the world’s first compact upright proton therapy treatment on 4 June 2026. Dana-Farber Cancer Institute and McLaren Health Care are among the institutions bringing the upright platform into their programmes — adoption that spans world-leading academic centers and
LUMI AI Factory Selects IQM to Deploy Advanced Quantum Computer, Accelerating Hybrid HPC and AI Development8.7.2026 14:00:00 CEST | Press release
The Halocene H4 quantum computer, named LUMI-IQ, will be delivered and installed in 2027 The system will be hosted at CSC – IT Center for Science in Finland and integrated into the LUMI AI Factory The system will provide researchers, industry innovators, and developers across Europe with a unique, advanced experimental platform where quantum computing and artificial intelligence converge The LUMI AI Factory, led by CSC – IT Center for Science, has selected IQM Quantum Computers (Nasdaq: IQMX) to deliver IQM Halocene H4, an advanced quantum computer aimed at accelerating hybrid high-performance computing, artificial intelligence, and quantum computing capabilities. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260708006791/en/ LUMI AI Factory selects IQM to deploy advanced quantum computer, accelerating hybrid HPC and AI development IQM Halocene H4 is the first and most advanced on-premises superconducting quantum computer o
Merck Announces FDA Breakthrough Therapy Designation for Enpatoran in Lupus Patients With Active Skin Manifestations8.7.2026 14:00:00 CEST | Press release
Enpatoran could address a significant unmet need in lupus, specifically targeting cutaneous manifestations of the disease, which currently have no approved therapiesFDA's decision was supported by Phase 2 WILLOW study results, which demonstrated meaningful symptoms improvement, particularly among patients with active cutaneous manifestationsEnpatoran's potential to go beyond current treatment standards in lupus prompted FDA´s breakthrough designation, which is designed to expedite drug development and reviewNot intended for Canada-, UK- or US-based media Merck, a leading science and technology company, today announced that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to enpatoran for the treatment of lupus with active cutaneous manifestations. Enpatoran is an oral selective toll-like receptor (TLR) 7/8 inhibitor, designed to modulate pathways central to lupus-related inflammation. “For the 85% of lupus patients whose disease includes skin manif
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom